Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|May 17, 2023
[PARP inhibitors - A better selection of patients]Marc Senglet, Grégoire Berthod, Marie-Gabrielle Courtes, et al.
Plos One|October 8, 2020
Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?Marta Fadda, Pierre O Chappuis, Maria C Katapodi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 16, 2014
Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutationsMaria Caiata-Zufferey, Olivia Pagani, Viviane Cina, et al.
JAMA Oncology|August 10, 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJens Huober, Patrik Weder, Karin Ribi, et al.
Scientific Reports|March 6, 2023
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancerChristoph Mamot, Andreas Wicki, Ursula Hasler-Strub, et al.
Pageof 1